VEGFA (Bevacizumab) Recombinant Monoclonal Antibody

The VEGFA (Bevacizumab) Recombinant Monoclonal Antibody is applicable for the following applications: ELISA. Host: Human. Species Reactivity: Human (Homo sapiens) . Immunogen: Recombinant Human VEGFA protein. Accession Number: P15692. Target Synonyms: glioma-derived endothelial cell mitogen; MGC70609; MVCD1; Vascular endothelial growth factor A; Vascular Endothelial Growth Factor; Vascular permeability factor; VEGF; VEGF-A; VEGF165; Vegfa; VEGFA_HUMAN; VPF. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Product Specifications

Short Description

The VEGFA (Bevacizumab) Recombinant Monoclonal Antibody is applicable for the following applications: ELISA

Accession Number

P15692

Host

Human

Reactivity

Human (Homo sapiens)

Immunogen

Recombinant Human VEGFA protein

Target

VEGFA

Clonality

Recombinant Monoclonal

Clone

16000000000000

Conjugation

Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.

Applications

ELISA

Field of Research

Others

Purification

Affinity chromatography

Concentration

Lot specific. Please inquire or refer to the datasheet included in the product pouch.

Format

Liquid

Buffer

0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4

Shipping Conditions

Ice packs

Storage Conditions

2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

Fragment

IgG1

Target Alternative Name

Glioma-derived endothelial cell mitogen; MGC70609; MVCD1; Vascular endothelial growth factor A; Vascular Endothelial Growth Factor; Vascular permeability factor; VEGF; VEGF-A; VEGF165; Vegfa; VEGFA_HUMAN; VPF